Ingrown nail correction device using 3D-printed thermoplastic polyurethane and nickel-titanium shape memory alloy
To the Editor: (Source: Clinics in Dermatology)
Source: Clinics in Dermatology - November 7, 2023 Category: Dermatology Authors: Hyun Jee Kim, Esther Kim, Hwa Jung Yook, Chul Hwan Bang, Ji Hyun Lee, Young Min Park, Yeong Ho Kim Tags: Correspondence Source Type: research
The Ethics of Facility Fees for Dermatology Clinics
As dermatologists who work at an academic institution that has established the dermatology clinic as a free-standing hospital-based clinic that charges a hospital facility fee for each visit, we are conflicted with the ethics of this scenario. Our services could obviously be provided in outpatient setting without this additional fee. What are the ethical pros and con of facility fee dermatology clinics (Table 1)? (Source: Clinics in Dermatology)
Source: Clinics in Dermatology - November 2, 2023 Category: Dermatology Authors: Kelley Sharp, Steven Brett Sloan, Jane M. Grant-Kels Tags: Correspondence Source Type: research
Metoposcopy Redux
Phrenology is the pseudoscience in which practitioners claim that they can discern one's character and personality traits by studying the structure of the skull. Long before "head bumps" were viewed as determinants of character, skin lines were analyzed to provide similar information and to divine one's future. Palmistry, also called chiromancy, is the interpretation of the lines of the palms and is one of the oldest forms of divination. A similar pseudoscience, metoposcopy, believes that facial lines and marks, mainly forehead lines, can reveal one's personality and foretell events in one's future. (Source: Clinics in Dermatology)
Source: Clinics in Dermatology - November 2, 2023 Category: Dermatology Authors: Kristen Toren, Jennifer S. Tromberg, Scott A. Norton Source Type: research
Cover 2 - Editorial Board with barcode
(Source: Clinics in Dermatology)
Source: Clinics in Dermatology - November 1, 2023 Category: Dermatology Source Type: research
Table of Contents
(Source: Clinics in Dermatology)
Source: Clinics in Dermatology - November 1, 2023 Category: Dermatology Source Type: research
Ocular and eyelid involvement in collagen vascular diseases. Part II. Dermatomyositis, Scleroderma, and Sarcoidosis
Collagen vascular disease is a heterogeneous group of autoimmune diseases that affect multiple organ systems. Sjogren's syndrome, dermatomyositis, scleroderma, systemic lupus erythematosus, and sarcoidosis are collagen vascular diseases that often present with characteristic cutaneous manifestations. Although less known, various ocular manifestations that affect both external and internal structures of the eye can also be seen in these conditions. Multidisciplinary management between dermatologists and ophthalmologists is essential in the early diagnosis and management of collagen vascular diseases affecting both the skin ...
Source: Clinics in Dermatology - October 30, 2023 Category: Dermatology Authors: Sueheidi Santiago, Ndidi Enwereji, Christina Jiang, Khayyam Durrani, Sona Chaudhry, Jun Lu Source Type: research
Continuing medical education in dermatology: The possible use of artificial intelligence
Artificial intelligence (AI) large language models such as ChatGPT and Claude have exhibited considerable medical prowess. From performing well on dermatology boards to delivering empathetic responses to patient questions, AI remains an evolving entity in medicine.1,2 (Source: Clinics in Dermatology)
Source: Clinics in Dermatology - October 28, 2023 Category: Dermatology Authors: Kripa Ahuja, Grace DeSena, Peter Lio Tags: Correspondence Source Type: research
Continuing Medical Education in Dermatology: The Possible Use of AI
For healthcare practitioners, continuing medical education (CME) not only serves as a requirement for license maintenance but also enforces a main tenant of medicine: lifelong learning.3 Most CME systems use an hour-related credit system, where one hour of CME activity equals one credit.3 For quiz-based credits, typically a passing score of 70% must be achieved to receive full credit. The purpose of this study was to assess whether ChatGPT or Claude could achieve the passing score needed to receive credit on dermatology CME questions.100 publicly available CME questions across 10 categories from the American Academy of Der...
Source: Clinics in Dermatology - October 28, 2023 Category: Dermatology Authors: Kripa Ahuja, Grace DeSena, Peter Lio Tags: Correspondence Source Type: research
The Cancer Genome Atlas for uveal melanoma is predictive of patient outcomes
Uveal melanoma (UM) is the most common primary eye malignancy. Despite excellent local tumor rates, UM is a life-threatening disease with moderate systemic metastatic rates. In the past, certain clinical features were shown to be predictive of patient prognosis, including tumor thickness, tumor diameter, ciliary body involvement, and histopathologic factors. Genetic markers have lately been used to predict patient outcomes. The Cancer Genome Atlas (TCGA) is a worldwide effort developed by the National Cancer Institute and the National Human Genome Research Institute to study numerous mutations in various cancer types. (Sou...
Source: Clinics in Dermatology - October 25, 2023 Category: Dermatology Authors: Zeynep Bas, Jane M. Grant-Kels, Carol L. Shields Source Type: research
The Cancer Genome Atlas (TCGA) for Uveal Melanoma is Predictive of Patient Outcomes
Uveal melanoma (UM) is the most common primary eye malignancy. Despite excellent local tumor rates, UM is still a life-threatening disease with moderate systemic metastatic rates. In the past, certain clinical features were shown to be predictive of patient prognosis, including tumor thickness, tumor diameter, ciliary body involvement, and histopathologic factors. Genetic markers have lately been used to predict patient outcomes. The Cancer Genome Atlas (TCGA) is a worldwide effort developed by the National Cancer Institute and the National Human Genome Research Institute to study numerous mutations in various cancer types...
Source: Clinics in Dermatology - October 25, 2023 Category: Dermatology Authors: Zeynep Bas, Jane M. Grant-Kels, Carol L. Shields Source Type: research
Periocular and ocular surface nonmelanoma skin cancer
Periocular and ocular surface nonmelanoma malignancies, including basal cell carcinoma (BCC), squamous cell carcinomas (SCC), and ocular surface squamous neoplasia (OSSN), are rare, but their management requires special considerations. The most common periocular malignancy is BCC, which constitutes 80% to 96% of tumors, followed by SCC, which represents 5% to 10% of tumors. OSSN represents a spectrum of diseases that encompass dysplastic alteration to the squamous epithelium of the eye. OSSN ranges from squamous dysplasia to conjunctival intraepithelial neoplasia/carcinoma in situ to invasive SCC, which is the most common ...
Source: Clinics in Dermatology - October 20, 2023 Category: Dermatology Authors: Jette Hooper, Kimberly Shao, Paula W. Feng, Madina Falcone, Hao Feng Source Type: research
Periocular and ocular surface non-melanoma skin cancer
Periocular and ocular surface non-melanoma malignancies, including basal cell carcinoma (BCC), squamous cell carcinomas (SCC), and ocular surface squamous neoplasia (OSSN), are rare, but their management requires special considerations. The most common periocular malignancy is BCC which comprises 80-96% of tumors, followed by SCC which represents 5-10% of tumors. OSSN represents a spectrum of diseases that encompass dysplastic alteration to the squamous epithelium of the eye. OSSN ranges from squamous dysplasia to conjunctival intraepithelial neoplasia/carcinoma in situ to invasive SCC, which is the most common ocular mali...
Source: Clinics in Dermatology - October 20, 2023 Category: Dermatology Authors: Jette Hooper, Kimberly Shao, Paula W. Feng, Madina Falcone, Hao Feng Source Type: research
Understanding Choroidal Nevus Risk Factors for Transformation into Melanoma
Choroidal nevus is a common intraocular tumor in the United States, found in approximately 5% of Caucasian adults. The three main risks of melanocytic choroidal nevus include vision loss from subfoveal nevus, development of subretinal fluid, and transformation of nevus into melanoma, a malignant counterpart. In this review, we will explore clinical risk factors that predict benign melanocytic choroidal nevus transformation into malignant choroidal melanoma. Based on a large analysis of 2,355 cases that were monitored longitudinally using multimodal imaging, the most recent list of clinical features include tumor Thickness ...
Source: Clinics in Dermatology - October 20, 2023 Category: Dermatology Authors: Joseph D. DeSimone, Charlotte N. Shields, Nicholas E. Kalafatis, Molly R. Marous, Charlotte L. Marous, Jerry A. Shields, Carol L. Shields Source Type: research
Skin and Eye Diseases Part II
Ophthalmologists and dermatologists collaborate frequently for diseases that impact the skin and eyes as well as for lesions that are located peri-ocularly. Close collaboration between our two specialties results in better outcomes for our patients. In Part 1 of our series published in Clinics in Dermatology1 we predominantly dealt with inflammatory diseases.[1] In part II we address collagen vascular diseases, infectious diseases (Sexually Transmitted Infections, HIV and COVID) and malignant neoplastic processes.[2] (Source: Clinics in Dermatology)
Source: Clinics in Dermatology - October 20, 2023 Category: Dermatology Authors: Andrzej Grzybowski, Jane M. Grant-Kels Tags: Commentary Source Type: research
Iris melanoma: Review of clinical features, risks, management, and outcomes
Primary uveal melanoma is rare and affects approximately 8,000 persons per year worldwide. This malignancy can involve the iris, ciliary body, and choroid. Of these three structures, the iris is the least commonly affected site, representing only 4% of all uveal melanomas. Iris melanoma can arise from iris melanocytic nevus, iris melanocytosis, or de novo. In a longitudinal study of 1,611 patients with iris nevus, transformation into melanoma, using Kaplan-Meier estimates, was found in 2.6% by five years and in 4.1% by 10 years. (Source: Clinics in Dermatology)
Source: Clinics in Dermatology - October 19, 2023 Category: Dermatology Authors: Elliot Cherkas, Nicholas E. Kalafatis, Molly R. Marous, Carol L. Shields Source Type: research
